Bioventus (BVS) Return on Capital Employed (2021 - 2026)

Bioventus' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 11.08% for Q1 2026.

• Quarterly Return on Capital Employed rose 1394.0% year-over-year to 11.08% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.08% (up 1394.0% YoY) and the FY2025 annual result came in at 9.9%, up 1261.0% from the prior year.
• Return on Capital Employed was 11.08% for Q1 2026 at Bioventus, up from 10.14% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 11.08% in Q1 2026 and bottomed at 33.35% in Q3 2023.
• A 5-year average of 5.8% and a median of 3.02% in 2022 frame the typical range for Return on Capital Employed.
• Annual changes were most pronounced in 2023 — Return on Capital Employed tumbled 3046 bps — and 2024, when it soared 2926 bps.
• Bioventus' Return on Capital Employed stood at 15.47% in 2022, then grew by 17 bps to 12.86% in 2023, then soared by 78 bps to 2.82% in 2024, then surged by 459 bps to 10.14% in 2025, then advanced by 9 bps to 11.08% in 2026.
• Business Quant data shows BVS's Return on Capital Employed at 11.08% in Q1 2026, 10.14% in Q4 2025, and 7.78% in Q3 2025.